Epigenetic mechanisms of Ash1L in transcriptional activation
Ash1L 在转录激活中的表观遗传机制
基本信息
- 批准号:10399431
- 负责人:
- 金额:$ 33.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:ASH1L geneAddressBindingBiochemicalBiological AssayCRISPR/Cas technologyCellsComplexCryoelectron MicroscopyDevelopmentDiseaseDrosophila genusES Cell LineEnzymesEpigenetic ProcessEventGene ActivationGene ExpressionGenesGeneticGenetic TranscriptionGenetic studyHistone H3HistonesHomologous GeneImpairmentIn VitroIndividualLeadLinkLysineMLL geneMalignant NeoplasmsMammalian CellMammalsMediatingMethylationMixed-Lineage LeukemiaModelingModificationMolecularMusMutateNucleic Acid Regulatory SequencesPhenotypePlayPolycombProcessProteinsReaderResearch InstituteRoleStructureTailTimeTranscriptional Activationbasedesignembryonic stem cellepigenetic regulationgene repressiongenetic analysisgenome editinghistone methylationhistone methyltransferasehistone modificationinhibitormutantnew therapeutic targetnext generation sequencingpromoterrecruitstem cell differentiationtranscription factor
项目摘要
Project Abstract
Epigenetic modifications at transcriptional regulatory regions play an important role in facilitating lineage-specific
gene expression during stem cell differentiation. In addition to lineage-specific transcription factors,
Trithroax-group (TxG)-group proteins promote lineage-specific gene expression through antagonizing the
Polycomb-mediated transcriptional repression. In mammals, Mll1/Mll2 (Mixed Lineage Leukemia) and Ash1L
(Absent, Small, or Homeotic discs 1-Like) complexes are two TxG complexes that mediate covalent histone
modifications through their histone methyltransferase (HMTase) activities towards histone H3 lysine 4 and
histone H3 lysine 36 respectively. Although previous genetic studies have revealed that Mll1/Mll2 and Ash1L
complexes are functionally involved in a common epigenetic regulatory process, it remains unknown how these
two complexes are connected at the molecular level to carry out their functions in transcriptional activation.
Additionally, in contrast to the well-studied Mll1/Mll2 complexes and histone H3K4 methylation, the functions of
Ash1L and its mediated histone H3K36 methylation at promoters are largely unknown. In an effort to address
these fundamental questions, we purified the Ash1L-interacting proteins and identified Spindlin1 (Spin1), a
histone H3K4me3-specific reader, physically binds to Ash1L. Deletion of either Ash1L or Spin1 in mouse
embryonic stem cells impairs the expression of early lineage-specific genes upon induced differentiation,
suggesting a functional connection between Spin1 and Ash1L in cells. Built upon these results, we propose a
new model to unify the function of Mll1/Mll2 and Ash1L in transcriptional activation. In this model, Mll1/Mll2,
Spin1, and Ash1L form an epigenetic regulatory axis, in which the individual component is sequentially recruited
to the lineage-specific gene promoters to mediate histone modifications during transcriptional activation.
Specifically, Spin1 plays a central role in connecting Mll1/Mll2 and Ash1L by recruiting Ash1L to the
H3K4me3-marked lineage-specific gene promoters. To understand the functional role of individual components
in this Mll1/Mll2-Spin1-Ash1L epigenetic regulatory axis, we will combine biochemical assays, CRISPR/Cas9-
mediated genome editing, and next generation sequencing-based genetic analysis to dissect individual
regulatory step proposed in the working model. Specifically, we will determine (1) whether Ash1L and its
HMTase activity are required for its function in facilitating transcriptional activation; (2) the molecular
mechanisms for the recruitment of Ash1L to gene promoters; (3) the structural basis underlying the interaction
between Ash1L, Spin1 and histone H3K4me3. Completion of this study will not only significantly advance our
understanding on the basic epigenetic mechanisms regulating the lineage-specific gene activation, but also
reveal new therapeutic targets for blocking aberrant gene activation in cancers.
项目摘要
转录调控区的表观遗传修饰在促进谱系特异性表达中起重要作用。
干细胞分化过程中的基因表达。除了谱系特异性转录因子,
Trithroax-group(TxG)-group蛋白通过拮抗
多梳介导的转录抑制。在哺乳动物中,Mll 1/Mll 2(混合谱系白血病)和Ash 1 L
(缺失、小或同源异型盘1样)复合物是两种TxG复合物,其介导共价组蛋白
通过其对组蛋白H3赖氨酸4的组蛋白甲基转移酶(HMTase)活性进行修饰,
组蛋白H3赖氨酸36。尽管先前的遗传学研究已经揭示了Mll 1/Mll 2和Ash 1 L
复合物在功能上参与了一个共同的表观遗传调控过程,目前还不清楚这些复合物是如何被激活的。
两个复合物在分子水平上连接,以实现它们在转录激活中的功能。
此外,与研究充分的Mll 1/Mll 2复合物和组蛋白H3 K4甲基化相反,
Ash 1 L及其介导的组蛋白H3 K36启动子甲基化在很大程度上未知。为了解决
为了解决这些基本问题,我们纯化了Ash 1 L相互作用蛋白,并鉴定了Spindlin 1(Spin 1),
组蛋白H3 K4 me 3特异性阅读器,与Ash 1 L物理结合。小鼠中Ash 1 L或Spin 1的缺失
胚胎干细胞在诱导分化时损害早期谱系特异性基因的表达,
这表明细胞中Spin 1和Ash 1 L之间存在功能联系。基于这些结果,我们提出了一个
新的模型来统一Mll 1/Mll 2和Ash 1 L在转录激活中的功能。在该模型中,Mll 1/Mll 2,
Spin 1和Ash 1 L形成了一个表观遗传调控轴,其中单个组分被顺序募集
谱系特异性基因启动子介导转录激活过程中的组蛋白修饰。
具体而言,Spin 1通过将Ash 1 L募集到Mll 1/Mll 2和Ash 1 L中而在连接Mll 1/Mll 2和Ash 1 L中起核心作用。
H3 K4 me 3标记的谱系特异性基因启动子。了解各个组件的功能作用
在这个Mll 1/Mll 2-Spin 1-Ash 1 L表观遗传调控轴中,我们将联合收割机生化测定、CRISPR/Cas9-
介导的基因组编辑和下一代基于测序的遗传分析,
工作模式中提出的监管步骤。具体而言,我们将确定(1)Ash 1 L及其
HMTase活性是其促进转录激活的功能所必需的;(2)HMTase的分子生物学活性,
Ash 1 L募集到基因启动子的机制;(3)相互作用的结构基础
Spin 1和组蛋白H3 K4 me 3之间的关系。这项研究的完成不仅将大大提高我们的
了解调节谱系特异性基因激活的基本表观遗传机制,
揭示了阻断癌症中异常基因激活的新治疗靶点。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SMYD5 is a histone H3-specific methyltransferase mediating mono-methylation of histone H3 lysine 36 and 37.
- DOI:10.1016/j.bbrc.2022.02.043
- 发表时间:2022-04-09
- 期刊:
- 影响因子:3.1
- 作者:Aljazi MB;Gao Y;Wu Y;He J
- 通讯作者:He J
Impaired KDM2B-mediated PRC1 recruitment to chromatin causes defective neural stem cell self-renewal and ASD/ID-like behaviors.
受损的KDM2B介导的PRC1募集到染色质导致神经干细胞自我更新和ASD/ID样行为导致缺陷。
- DOI:10.1016/j.isci.2022.103742
- 发表时间:2022-02-18
- 期刊:
- 影响因子:5.8
- 作者:Gao Y;Duque-Wilckens N;Aljazi MB;Moeser AJ;Mias GI;Robison AJ;Zhang Y;He J
- 通讯作者:He J
Cell Signaling Coordinates Global PRC2 Recruitment and Developmental Gene Expression in Murine Embryonic Stem Cells.
- DOI:10.1016/j.isci.2020.101646
- 发表时间:2020-11-20
- 期刊:
- 影响因子:5.8
- 作者:Aljazi MB;Gao Y;Wu Y;Mias GI;He J
- 通讯作者:He J
Neural Hyperactivity Is a Core Pathophysiological Change Induced by Deletion of a High Autism Risk Gene Ash1L in the Mouse Brain.
- DOI:10.3389/fnbeh.2022.873466
- 发表时间:2022
- 期刊:
- 影响因子:3
- 作者:Gao Y;Aljazi MB;He J
- 通讯作者:He J
Kdm6b Haploinsufficiency Causes ASD/ADHD-Like Behavioral Deficits in Mice.
- DOI:10.3389/fnbeh.2022.905783
- 发表时间:2022
- 期刊:
- 影响因子:3
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jin He其他文献
Jin He的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jin He', 18)}}的其他基金
Epigenetic mechanisms of histone methyltransferase ASH1L in autism spectrum disorder
组蛋白甲基转移酶 ASH1L 在自闭症谱系障碍中的表观遗传机制
- 批准号:
10743048 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Epigenetic mechanisms of Ash1L in transcriptional activation
Ash1L 在转录激活中的表观遗传机制
- 批准号:
9923726 - 财政年份:2018
- 资助金额:
$ 33.36万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Research Grant